University of Arizona Researchers Embark on Asthma-Related Precision Medicine Initiative | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

University of Arizona Researchers Embark on Asthma-Related Precision Medicine Initiative

January 24, 2018
by Rajiv Leventhal
| Reprints

University of Arizona researchers are launching an international consortium with the goal to stop asthma in childhood and continue work toward an overall cure for the disease.

The researchers will specifically set out to determine if better regulation of a protein found in lung cells might impact persistence of asthma from childhood to adulthood, working toward personalized therapies for people with adult chronic asthma.

Stefano Guerra, M.D., Ph.D., a professor in the University of Arizona Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, recently received a $3.6 million, five-year grant from the National Institute of Allergy and Infectious Diseases to study the protein CC16, a biomarker of injury to epithelial cells that line the lungs and are believed to be a protective mediator in the airway inflammatory process. The protein is produced mainly by “club cells,” also known as “bronchiolar exocrine cells,” in the outer airways of the lungs, but can be measured in blood circulation, as the researchers explained in an announcement.

“The project establishes an international consortium among some of the world’s leading asthma research groups that provide unique data on thousands of participants followed from birth well into their adult life,” Dr. Guerra said in a press release.

These groups include the Tucson Children’s Respiratory Study, launched in 1980 by the Arizona Respiratory Center (now the UA Health Sciences Asthma and Airway Disease Research Center), Sweden’s BAMSE (the Swedish abbreviation for Children, Allergy, Milieu, Stockholm, Epidemiology) and the United Kingdom’s Manchester Asthma and Allergy Study (MAAS). Each involve longitudinal research with observation of patients over decades.

"This study builds upon the already outstanding work on asthma-related research at the University of Arizona to move forward on treatments for a disease that is affecting the quality of so many lives, especially our children," said UA President Robert C. Robbins. "Personalized medicine is the future of healthcare, and the UA is recognized as a leader in this emerging and vitally important area. I am excited to learn what Dr. Guerra and his colleagues find."

Guerra noted that ultimately, the team’s objective is to establish the value of CC16 as a protective factor from persistence of asthma (into adulthood) and evaluate its possible use in identifying which patients are at high risk and novel therapeutic interventions to help them.

If these studies help determine CC16 deficits’ role in persistent asthma, the next step would be to evaluate CC16 augmentation as a therapeutic intervention in this disease, by either administering the human recombinant CC16 protein (which already is being tested in airway diseases) or molecules that increase a body’s internal production of CC16, according to the researchers.

2018 Denver Health IT Summit

Renowned leaders in U.S. and North American healthcare gather throughout the year to present important information and share insights at the Healthcare Informatics Health IT Summits.

July 12 - 13, 2018 | Denver



Geisinger National Precision Health Hires Illumina Exec to Lead Business Development

Integrated health system Geisinger has hired a high-profile genetic counselor to head up business development for Geisinger National Precision Health, which was created to extend the Geisinger model on the national scene.

$30M VC Fund Launched to Spur Innovation in Cardiovascular Care

The American Heart Association, together with Philips and UPMC, has announced the launch of Cardeation Capital, a $30 million collaborative venture capital fund designed to spur healthcare innovation in heart disease and stroke care.

Epic Wins Labor Dispute in Closely Divided Supreme Court Decision

Epic Systems Corporation won a major labor-law ruling in the Supreme Court on Monday, centering around the extent of corporations’ right to force employees to sign arbitration agreements, and with a 5-4 ruling in its favor

Survey: Two-Thirds of Physician Practices Seeking Out Value-Based Care Consulting Firms

Most physician organizations are not prepared for the move to value-based care, and 95 percent CIOs of group practices and large clinics state they do not have the information technology or staff in-house needed to transform value-based care end-to-end, according to a recent Black Book Market Research.

Cumberland Consulting Buys LinkEHR, Provider of Epic Help Desk Services

Cumberland Consulting Group, a healthcare consulting and services firm, has acquired LinkEHR, which provides remote application support, including Epic help desk services.

Population Health Tool that Provides City-Level Data Expands to 500 Cities

A data visualization tool that helps city officials understand the health status of their population, called the City Health Dashboard, has now expanded to 500 of the largest cities in the U.S., enabling local leaders to identify and take action around the most pressing health needs in their cities and communities.